• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2013年至2023年韩国与痴呆症相关的死亡统计数据。

Dementia-related death statistics in Korea between 2013 and 2023.

作者信息

Lee Seokmin

机构信息

Statistics Research Institute, Statistics Korea, Daejeon, Korea.

出版信息

Ewha Med J. 2025 Apr;48(2):e35. doi: 10.12771/emj.2025.00304. Epub 2025 Mar 31.

DOI:10.12771/emj.2025.00304
PMID:40703373
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12277498/
Abstract

PURPOSE

This study aimed to analyze dementia-related death statistics in Korea between 2013 and 2023.

METHODS

The analysis utilized microdata from Statistics Korea's cause-of-death statistics. Among all recorded deaths, those related to dementia were extracted and analyzed using the underlying cause-of-death codes from the International Classification of Diseases, 10th revision.

RESULTS

The number of dementia-related deaths increased from 8,688 in 2013 to 14,402 in 2023. The crude death rate rose from 17.2 per 100,000 in 2013 to 28.2 per 100,000 in 2023, although the age-standardized death rate declined from 9.7 to 8.7 over the same period. The dementia death rate is 2.1 times higher in women than in men, and mortality among individuals aged 85 and older exceeds 976 per 100,000. By specific cause, Alzheimer's disease accounted for 77.1% of all dementia deaths, and by place, the majority occurred in hospitals (76.2%), followed by residential institutions including nursing homes (15.3%) in 2023.

CONCLUSION

The rising mortality associated with dementia, especially Alzheimer's disease, highlights a growing public health concern in Korea. These findings support the need for enhanced prevention efforts, improved quality of care, and targeted policies addressing the complexities of dementia management. It is anticipated that this empirical analysis will contribute to reducing the social burden.

摘要

目的

本研究旨在分析2013年至2023年韩国与痴呆症相关的死亡统计数据。

方法

该分析使用了韩国统计局死因统计的微观数据。在所有记录的死亡病例中,提取与痴呆症相关的病例,并使用国际疾病分类第10版的根本死因编码进行分析。

结果

与痴呆症相关的死亡人数从2013年的8688人增加到2023年的14402人。粗死亡率从2013年的每10万人17.2人上升到2023年的每10万人28.2人,尽管同期年龄标准化死亡率从9.7降至8.7。女性的痴呆症死亡率是男性的2.1倍,85岁及以上人群的死亡率超过每10万人976人。按具体病因,阿尔茨海默病占所有痴呆症死亡病例的77.1%,按地点划分,2023年大多数死亡发生在医院(76.2%),其次是包括养老院在内的住宿机构(15.3%)。

结论

与痴呆症相关的死亡率上升,尤其是阿尔茨海默病,凸显了韩国日益严重的公共卫生问题。这些发现支持加强预防工作、提高护理质量以及制定针对性政策以应对痴呆症管理复杂性的必要性。预计这一实证分析将有助于减轻社会负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372e/12277498/fe9d50b40d79/emj-2025-00304f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372e/12277498/9da08820a46c/emj-2025-00304f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372e/12277498/27e5ac6a5894/emj-2025-00304f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372e/12277498/fe9d50b40d79/emj-2025-00304f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372e/12277498/9da08820a46c/emj-2025-00304f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372e/12277498/27e5ac6a5894/emj-2025-00304f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/372e/12277498/fe9d50b40d79/emj-2025-00304f3.jpg

相似文献

1
Dementia-related death statistics in Korea between 2013 and 2023.2013年至2023年韩国与痴呆症相关的死亡统计数据。
Ewha Med J. 2025 Apr;48(2):e35. doi: 10.12771/emj.2025.00304. Epub 2025 Mar 31.
2
All-Cause Mortality and Specific Causes of Death in Autism: A Nationwide Analysis.自闭症患者的全因死亡率及特定死因:一项全国性分析。
Autism Adulthood. 2025 Feb 5;7(1):81-92. doi: 10.1089/aut.2023.0103. eCollection 2025 Feb.
3
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
4
Sexual Harassment and Prevention Training性骚扰与预防培训
5
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.
6
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
7
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
8
Special care units for dementia individuals with behavioural problems.针对有行为问题的痴呆症患者的特殊护理单元。
Cochrane Database Syst Rev. 2009 Oct 7(4):CD006470. doi: 10.1002/14651858.CD006470.pub2.
9
Nimodipine for primary degenerative, mixed and vascular dementia.尼莫地平用于原发性退行性、混合型和血管性痴呆。
Cochrane Database Syst Rev. 2001(1):CD000147. doi: 10.1002/14651858.CD000147.
10
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.

本文引用的文献

1
Impact of COVID-19 pandemic on mortality and cognitive function of dementia patients: Tochigi Dementia Cohort Study.新型冠状病毒肺炎大流行对痴呆症患者死亡率和认知功能的影响:栃木痴呆队列研究
J Neurol Sci. 2024 Jan 15;456:122840. doi: 10.1016/j.jns.2023.122840. Epub 2023 Dec 10.
2
Association between Dementia and Clinical Outcome after COVID-19: A Nationwide Cohort Study with Propensity Score Matched Control in South Korea.新型冠状病毒肺炎后痴呆与临床结局的关联:韩国一项倾向评分匹配对照的全国队列研究
Psychiatry Investig. 2021 Jun;18(6):523-529. doi: 10.30773/pi.2021.0064. Epub 2021 Jun 24.
3
Dementia is an age-independent risk factor for severity and death in COVID-19 inpatients.
痴呆症是 COVID-19 住院患者严重程度和死亡的与年龄无关的风险因素。
Alzheimers Dement. 2021 Nov;17(11):1818-1831. doi: 10.1002/alz.12352. Epub 2021 Apr 21.
4
Is Dementia More Fatal Than Previously Estimated? A Population-based Prospective Cohort Study.痴呆症是否比先前估计的更致命?一项基于人群的前瞻性队列研究。
Aging Dis. 2019 Feb 1;10(1):1-11. doi: 10.14336/AD.2018.0123. eCollection 2019 Feb.